 
  ; Petrakova Katarina; DiPrimeo Daniel; Wong Alvin; Martin Miguel; Chan Arlene; ExteNET Study Group;
; Petrakova Katarina; DiPrimeo Daniel; Wong Alvin; Martin Miguel; Chan Arlene; ExteNET Study Group;   | Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. | 
|---|---|---|---|---|
| 2023 | Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial | Holmes Frankie A; Moy Beverly; Delaloge Suzette; Chia Stephen KL; Ejlertsen Bent; Mansi Janine; Iwata Hiroji; Gnant Michael; Buyse Marc; Barrios Carlos H; | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a | 
| 2022 | 229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)  | Djurmez, Ognjen; Calamac, Marina; Dimitrijevic, M; Vukosavljevic, JG; Serovic, Kristina; Oblakovic-Babic, Jelena S; Stanic, Nemanja S; Minic, Ivana Z    ; Tomasevic, Zorica I    ; Bozovic-Spasojevic, Ivana M    | Konferencijski rad | Mp kategorija će biti prikazana naknadno. | 
| 2021 | White blood cell subsets in HER2-positive breast cancer patients treated with trastuzumab in relation to clinical outcome  | Matić Ivana Z    ; Grujić Milica; Kolundžija Branka; Damjanović Ana    ; Tomašević Zorica    ; Crnogorac Marija Đ    ; Dzodic Radan  ; Filipović Ivana Lj    ; Ždrale Zdravko; Erić-Nikolić Aleksandra    ; | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 | 
| 2020 | Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study  | Kolberg, Hans-Christian; Colleoni, Marco A; Sawa-Demetriou, G; Santi, Patricia Xavier; Tesch, Hans; Fujiwara, Yasuhiro; Tomasevic, Zorica I    ; Hanes, Vladimir | Naučni članak | 21aM21a - Vodeći međunarodni časopis kategorije M21a | 
| 2020 | Incidence of non-breast cancer neoplasms (non-BCN) diagnosed prior and subsequent to breast cancer (BC): Single institution experience.  | Tomasevic, Zorica I    ; Tomasevic, Zoran M  ; Grujicic, Danica M  ; Nikitovic, Marina R    ; Milovanovic, Zorka M    | Konferencijski rad | Mp kategorija će biti prikazana naknadno. | 
| 2019 | AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan)  | Todorovic, Vladimir; ...; Babovic, Nada Lj; ...; Četniković, Bojana; Ceric, Timur; ...; Dzamic, Zoran M    ; Dzodic, Radan R  ; Eri, Živka  ; 
...; Knežević-Ušaj, Slavica F   ; Kovcin, Vladimir N; ...; Markovic, Ivan Z; Markovic, Milan; Mijalkovic, Nenad; ...; Pantelic, Aleksandra; Popović, Lazar S    ; Radosavljevic, Davorin Z; ...; Radulovic, Sinisa S; ...; Rosic, Ivana; ...; Stamatović, Ljiljana    ; ...; Tesanovic, Dusanka D; Tomasevic, Zorica I    ; Tomasevic, Zoran M; ...; Vasovic, Suzana; Vicko, Ferenc    ; ...; Zarić, Bojan    ; ...; (broj, koautora 65); | Naučni članak | 23M23 - Međunarodni časopis kategorije M23 | 
| 2019 | Breast cancer and recurrent thrombosis - Results from prospective single center study | Kovač, Mirjana  ; Kovac, Zeljko; Tomasević, Zorica    ; Tomić, Branko    ; Gvozdenov, Maja    ; Radojković, Dragica    | Informativni prilog | 22M22 - Međunarodni časopis kategorije M22 | 
| 2019 | Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia  | Krivokuća, Ana    ; Boljević, Ivana  ; Jovandic, Stevo; Magic, Zvonko    ; Mandić, Aljoša    ; Tomasevic, Zorica    ; Brankovic-Magic, Mirjana    | Naučni članak | 21M21 - Vodeći međunarodni časopis kategorije M21 | 
| 2018 | Abstract PD3-10: Safety results from a randomized, double-blind, phase 3 study of ABP 980 compared with trastuzumab in patients with breast cancer  | Kolberg, Hans-Christian; Demetriou, Georgia S; Zhang, Nan; Tomasevic, Zorica I    ; Hanes, Vladimir | Konferencijski rad | Mp kategorija će biti prikazana naknadno. | 
| 2018 | Paclitaxel-induced peripheral neuropathy in patients with operable breast cancer  | Serovic, Kristina; Tomasevic, Zoran M  ; Bozovic-Spasojevic, Ivana M    ; Minic, Ivana Z    ; Oblakovic-Babic, Jelena S; Jokic, Vladimir; Pusica, Aleksandra; Tomasevic, Zorica I    | Konferencijski rad | Mp kategorija će biti prikazana naknadno. | 
| 2018 | Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial  | von, Minckwitz Gunter; Colleoni, Marco A; Kolberg, Hans-Christian; Morales, Serafin; Santi, Patricia Xavier; Tomasevic, Zorica I    ; Zhang, Nan; Hanes, Vladimir | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ | 
| 2018 | Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE  | Popović, Lazar    ; Tomašević, Zorica    ; Stamatović, Ljiljana    ; Marković, Ivan    ; Matovina-Brko, Gorana  ; Buta,  Marko    ; Golubović, Andrija  ; Selaković, Vladimir; Trifunović, Jasna    ; Mutrezani, Zafir; | Naučni članak | 23M23 - Međunarodni časopis kategorije M23 | 
| 2017 | Prognostic importance of steroid receptor status for disease free and overall survival after surgical resection of isolated liver metastasis in breast cancer patients  | Zegarac, Milan    ; Nikolic. Srdjan    ; Gavrilovic, Dusica; Kolarevic, Daniela  ; Jevric, Marko    ; Nikolic-Tomasevic, Zorica    ; Kocic, Milan; Djurisic Igor    ; Inic, Zorka; Markovic, Ivan    ; | Naučni članak | 23M23 - Međunarodni časopis kategorije M23 | 
| 2017 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Group  | M. Miguel; F. Holmes; B. Ejlertsen; S. Delaloge; B. Moy; H. Iwata; G. von Minckwitz; S. Chia; J. Mansi; C. Barrios; | Naučni članak | 21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+ | 
| 2017 | Cerebellar metastases as the only brain metastatic site and correlation with molecular characteristics of primary breast cancer.  | Tomašević, Zorica I.    ; Tomasevic Zoran  ; Grujicic Danica  ; Z. Kovac; Milovanovic Z.orka    ; Minic Ivana    ; Kolarevic Daniela | Konferencijski rad | Mp kategorija će biti prikazana naknadno. | 
| 2017 | Characteristics of HER2 3+ metastatic breast cancer patients with long-term benefit of trastuzumab.  | Tomašević, Zorica I.    ; Tomašević, Zoran  ; Minić, Ivana    ; Kolarević, Daniela  | Konferencijski rad | Mp kategorija će biti prikazana naknadno. | 
| 2017 | Preporuke za praćenje bolesnica sa ranim karcinomom dojke;vodiči i svakodnevna klinička praksa  | Tomašević, Zorica I.    | Konferencijski rad | Mp kategorija će biti prikazana naknadno. | 
| 2017 | Biosimilari u onkologiji bazirano na ESMO position paper  | Tomašević, Zorica I.    | Konferencijski rad | Mp kategorija će biti prikazana naknadno. | 
| 2016 | Ne-epitelijalni maligni tumori ovarijuma  | Tomašević, Zorica    | Konferencijski rad | Mp kategorija će biti prikazana naknadno. | 
| 2016 | Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women  | Krivokuća, Ana    ; Čavić, Milena    ; Mališić, Emina    ; Dobričić, Jelena  ; Kolarević, Daniela  ; Tomašević, Zorica    ; Branković-Magić, Mirjana    | Naučni članak | 22M22 - Međunarodni časopis kategorije M22 |